Safety Study of MGA271 in Refractory Cancer
NCT01391143
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
179
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Melanoma
Renal Cell Carcinoma
Triple-negative Breast Cancer
Head and Neck Cancer
Bladder Cancer
Non-small Cell Lung Cancer
Interventions
BIOLOGICAL:
MGA271
Sponsor
MacroGenics